CHANGING ATTITUDES TO CONTRACEPTION AND REPRODUCTIVE HEALTH

organized in co-operation with Società Italiana della Riproduzione

FINAL PROGRAMME

7TH CONGRESS OF THE EUROPEAN SOCIETY OF CONTRACEPTION GENOVA, ITALY - APRIL 10-13, 2002 With simultaneous translation of the plenary sessions into Italian INTRODUCTION

Welcome to Genova 2002,

On behalf of the Organising and Scientific Committee we welcome you to the 7th ESC Congress in Genova, the old famous seaport in the Liguria region of Italy which enjoys a mild climate and great natural beauty. The title of the 7th Congress of the European Society of Contraception is "Attitudes, prevention and care to contraception and reproductive health".

Advances in scientific knowledge, research and development in recent decades have resulted in an increasingly wider choice of new contraceptive methods and improvements in the saf- ety and effectiveness of existing methods. However, on a global scale, every minute: 380 women become pregnant; 190 women face an unplanned or unwanted pregnancy; 110 women experience a pregnancy related complication; 40 women have an unsafe abortion; and every minute one woman dies from complications related to pregnancy and childbirth. One of the most important issues in improving reproductive health care is an approach on meeting people's needs rather than just reducing fertility. This implies a closing of the existing large regional and international gaps in quality services offered by reproductive health care provi- ders, programmes and contraceptive suppliers. Changed attitudes, new contraceptive deve- lopments, appropriateness of methods and introduction strategies needs to be disseminated rapidly over the next several years.

The Congress will start with a keynote lecture on "Contraception and society" and in the various sessions the social dimension of the contraceptive strategies will be widely debated. A practical emphasis will be put on the new achievements in the area of estrogen and proge- stogen receptors directly linked with the contraceptive methods. Large proportion of the time will be allocated to the presentation and discussion of the potential risks related to contracep- tion and family planning: the risk of STD, and for the users of OC the evaluation of the risk for deep venous thrombosis. Another interesting issue will be the use of OC at the end of fertile age taking in account the positive effects on the cycle and its protective effect on ovarian and endometrial carcinogenesis. Male contraception, postcoital contraception, as well as steriliza- tion and abortion, will be described as alternative methods of family planning. Of essential importance, the various aspects of contraceptive counselling will be illustrated and discussed with the aim to improve the compliance of the contraception, an essential part of the repro- ductive health.

Finally, it is our hope and belief that the title of the Congress and scientific programme of the con- gress will be acknowledged as a support to the perception of contraception not only as key inter- vention for improving female health care, but also as a human right.

P.G. Crosignani S.O. Skouby President Organising Committee President Scientific Committee

7TH CONGRESS OF THE EUROPEAN SOCIETY OF CONTRACEPTION 1 ORGANISATION

Executive Committee of the ESC S.O. Skouby (President) E. Aubény (Vice-President) M. Short (Secretary General) B. Pinter (Assistant Secretary) D. Cibula (Treasurer) A. Verougstraete (Assistant Treasurer) Board of Directors E. Aubény, France G. Bartfai, Hungary R.J.C.M. Beerthuizen, The Netherlands A. Bigrigg, United Kingdom V.B. Bruni, Italy D. Cibula, Czech Republic C. Coll Capdevila, Spain G. Creatsas, Greece S. Jones, Ireland M. Lech, Poland O.E. Loeber, The Netherlands P. Martínez, Spain M. Orlean, Latvia S. Özalp, Turkey B. Pinter, Slovenia A. Pretnar-Darovec, Slovenia V.N. Prilepskaya, Russia D.M. Rebelo, Portugal D. Serfaty, France M. Short, Ireland S.O. Skouby, Denmark V. Unzeitig, Czech Republic M.R. van Santen, Germany A. Verougstraete, Belgium A. Webb, United Kingdom A. Yeshaya, Israel Organisation secretariat ESC Central Office Orga-Med c.o., Congress Department Essenestraat 77, B-1740 Ternat, Belgium Tel. +32 2 582 08 52, Fax +32 2 582 55 15 [email protected]

2 7TH CONGRESS OF THE EUROPEAN SOCIETY OF CONTRACEPTION ORGANISATION

International Scientific Committee S.O. Skouby, Denmark (Chairman) E. Aubény, France V. Bruni, Italy C. Coll Capdevila, Spain P.G. Crosignani, Italy C. LaVecchia, Italy S. Özalp, Turkey B. Pinter, Slovenia J. Rademakers, The Netherlands Advisory Board L. Andolsek-Jeras, Slovenia J.J. Amy, Belgium E. Baulieu, France P. Benagiano, Italy G. Creatsas, Greece E. Diczfalusy, Sweden A.R. Genazzani, Italy A. Glasier, UK J. Newton, UK E. Nieschlag, Germany H. Schneider, Germany D. Serfaty, France P.F.A. Van Look, WHO, Switzerland R.H.W. van Lunsen, The Netherlands Organising Committee P.G. Crosignani, Italy (President) V. Bruni, Italy (Vice President) A. Lauria , Italy (Secretary General) L. Baldi, Italy (Treasurer) M. Short, Rep. of Ireland (Vice Secretary) D. Cibula, Czech Republic (Assistant Treasurer) E. Arisi, Italy (Member) N. Ragni, Italy (Member) P.L. Venturini, Italy (Member) A. Volpe, Italy (Member)

7TH CONGRESS OF THE EUROPEAN SOCIETY OF CONTRACEPTION 3 GENERAL INFORMATION (Items in alphabetic order)

Badges Congress badges should be worn by all participants at all times during the meeting and whilst visiting the exhibition area. No badge, no entry! Badges are colour-coded as follows:

• participants, ESC members YELLOW • participants, non members GREEN • organisers and staff RED • accompanying persons BROWN • exhibitors BLUE

Banking facilities Several banks are situated in proximity to the congress venue. Banks are open during week days only from 8.30 am to 13.00 pm and from 14.45 to 15.45.

Book of Abstracts You will find the Book of Abstracts in your congress bag. Additional copies can be purchased at the ESC stand.

Business Centre If needed, photocopying and fax facilities are available at the registration desk.

Certificate A certificate of attendance will be available on simple request at the registration desk, not sooner than Friday, lunch time.

Congress venue Congress Centre "Magazzini del Cotone" Porto Antico 16128 Genova, Italy www.cotonecongressi.it

4 7TH CONGRESS OF THE EUROPEAN SOCIETY OF CONTRACEPTION Currency As a member of the European monetary system, the lire has been replaced by the euro. Foreign currency may be exchanged at banks, exchange offices, travel agencies, hotels, airports and railway stations. All major credit cards (American Express, Diners, Master Card-Eurocard and Visa) are widely accepted in hotels, larger stores and restaurants.

General Assembly Friday, April 12, 17 :00 – 18 :30, Auditorium Only members of the European Society of Contraception, who paid their membership contribution for the year 2002, will have access to the General Assembly. If your mem- bership fee is not paid yet, you still can do so at the ESC stand.

Hotels See ‘Travel arrangements’

Insurance The Organising Committee cannot accept any liability.

Language The official language of the Congress is English. However, simultaneous translation to Italian will be provided for the plenary sessions.

Lunches and refreshments Breaks will be organised in the exhibition area. There will be lunch facilities in the Congress Centre, at your own expense. Several restaurants of all categories are located in the vicinity of the Congress Centre. The cafetaria of the Congress Centre will be open during the Congress.

Meeting point Should you wish to arrange to meet someone, the official meeting point is at the Registration desks.

Messages Messages will be displayed at the registration area on a special dedicated board.

6TH CONGRESS OF THE EUROPEAN SOCIETY OF CONTRACEPTION 5 On-site registrations All payments are expressed in EURO and can be paid either in EURO or in USD (exchange rate of the day).

on-site ESC members 500 Non-members 600 Residents, nurses, students* 400 Accompanying persons 150 Gala Dinner (Friday, April 12) 100

*Status must be evidenced by a written employers’ statement or copy of certificate.

Preview room ((1st floor) Speakers are kindly invited to submit their slides at least 60 minutes before their presentation to the preview room. Last minute control facilities will be available. Speakers working with PC projection, should contact the preview room manager as well for instructions.

Registration - information - help desk Foyer ‘Maestrale’, level 0. Opening hours: • Wednesday, 10 April 12:00 - 19:30 • Thursday, 11 April 07:45 - 17:30 • Friday, 12 April 08:00 - 17:30 • Saturday, 13 April 08:00 - 15:00

Registration package The registration for the participants includes • admission to the scientific sessions and exhibition, • abstract book, • final programme, • certificate of attendance, • coffee and tea during breaks, • welcome cocktail (Wednesday April 10, 2002), if ticked on the form

6 7TH CONGRESS OF THE EUROPEAN SOCIETY OF CONTRACEPTION The registration for the accompanying persons includes • admission to the exhibition area, • access to the opening ceremony, • welcome cocktail (Wednesday April 10, 2002), • city tour of Genova (Medieval Genova Tour)

Restaurants There are several restaurants offering national and international dishes (self-service, à la carte, Italian, pizzerias, snack bars) within walking distance of the Congress Centre.

Shopping One can go shopping everywhere, in the old streets (caruggi) of the historic centre as well as in the inland trade centres. Just walking along Via Orefici, Via Luccoli, Campetto, Soziglia, Via Macelli, Via Canneto and Sottoripa to find ancient and well established dealer firms or more fanciful artisan studios. In the modern centre, the best shopping areas are Via Roma, Piccapietra, Via XX Settembre and its surroundings. In the Porto Antico you will find a lot of shops that sel Genoese delicatessen, records, books and underwater outfits. From Monday to Saturday usual shopping hours are 10.00 to 19.00.

Taxis Taxis cannot be booked but easily found by calling 010/5966.

Travel arrangements Official congress agency:

BC Congressi Via XX Settembre, 14/4 16121 Genova, Italy Tel +390 10 595 70 60 Fax +390 10 595 85 48 [email protected]

BC Congressi will have a desk in the registration area with the aim to help you with travel and lodging facilities.

7TH CONGRESS OF THE EUROPEAN SOCIETY OF CONTRACEPTION 7 SOCIAL PROGRAMME

WEDNESDAY, APRIL 10, 2002 (Palazzo Ducale) 18:00 – 19:30 Opening Ceremony and Lecture 19:30 – 21:00 Welcome cocktail

The Opening Ceremony, Lecture and Welcome Cocktail will be held at Palazzo Ducale (Piazza Matteotti 9, Genova) and NOT at the Congress Centre as stated in the Second Announcement.

Palazzo Ducale was once the seat of government of the Republic of Genova and resident of the Doges. Following major restoration work, it is today a multi-purpose centre. Its appearance, not withstanding the different periods of construction and the different styles, is harmonious and elegant.

• Free of charge for participants and accompanying persons.

FRIDAY, APRIL 12, 2002 (Stazione Marittima) 20 :30 Gala Dinner

The main (optional) social event of the Congress will be the Gala Dinner at ‘Stazione Marittima’ (Ponte Dei Mille, 16126 Genova).

• Price: 100 EURO per person, pre-registration through the registration form was necessary. • Participants who have not booked on beforehand, can inform themselves at the registration desk to see if there are any places left. • A shuttle bus will bring (and return) the participants from the official congress hotels to (from) ‘Stazione Marittima’.

8 6TH CONGRESS OF THE EUROPEAN SOCIETY OF CONTRACEPTION Medieval Genova Tour on foot from 9:30 to 12:00 April 11 and 12

A visit to the historic core of the city: from the Cathedral of San Lorenzo (known since 878), with its splendid Gothic facade and its majestic interior, to the medieval church and the 15th century monastery of Santa Maria di Castello, passing through the characteristic maze of ancient narrow alleys, the famous "carruggi".

• Free of charge. Booking at the registration desk.

7TH CONGRESS OF THE EUROPEAN SOCIETY OF CONTRACEPTION 9 SCIENTIFIC PROGRAM

In general

• Main sessions (plenary) • Congress Sessions (keynote lectures and selected free communications) • Symposia • Posters • Workshops (interactive, max. 25 participants) • Meet the Experts (round-table discussion during lunch, max. 25 participants)

Plenary and Keynote Lectures will be given by internationally recognised invited speakers. A selection of free communications will be grouped by topic (see programme) and will be presented after a key-note lecture introduction. Symposia will be the forum for the pharmaceutical companies. Posters will carry equivalent scientific status to oral com- munications in the programme (see chapter 'Posters').

To keep the workshops interactive, the number of participants is limited to 25 per workshop (pre-registration through your registration form was necessary). Meet the expert sessions will be organised during lunch time, at which places are also limited (pre-registration through your registration form was necessary). If registered for the Workshops and/or Meet the Expert Sessions, participants will find a reminder in their personal envelope. A quick lunch will be available during the Meet the Expert Sessions (included in the registration fee).

10 7TH CONGRESS OF THE EUROPEAN SOCIETY OF CONTRACEPTION Faculty (Invited Speakers, Workshop Moderators, Experts, Chairmen)

Arisi E. (Italy) Pretnar-Darovec A. (Slovenia) Aubény E. (France) Rademakers J. (The Netherlands) Baird D.T. (United Kingdom) Ragni N. (Italy) Bartfai G. (Hungary) Semprini A. (Italy) Beerthuizen R.J.C.M. (The Netherlands) Serfaty D. (France) Benagiano P. (Switzerland Sjöberg N.O. (Sweden) Bentin - Ley U. (Denmark Short M. (Ireland) Blayo C. (France) Sitruk-Ware R.L. (USA) Bruni V.B. (Italy) Skouby S.O. (Denmark) Cibula D. (Czech Republic) Van Look P. (Switzerland) Claeys V. (Belgium) van Lunsen R.H.W. (The Netherlands) Coll C. (Spain) Venturini P.L. (Italy) Creatsas G. (Greece) Verougstraete A. (Belgium) Crosignani P.G. (Italy) Volpe A. (Italy) Diczfalusy E. (Sweden) Webb A. (United Kingdom) Drife J.O. (United Kingdom) Wu F. (United Kingdom) Farley T.M.M. (Switzerland) Yeshaya A. (Israel) Gaspard U. (Belgium) Zanetti A.R. (Italy) Glasier A.(United Kingdom) Gustafsson J.A. (Sweden) JespersenJ. (Denmark) Jones S. (Ireland) LaVecchia C. (Italy) Lech M. (Poland) Loeber O.E. (The Netherlands) Nieschlag E. (Germany) Orfila J. (France) Özalp S. (Turkey) Paavonen J. (Finland) Pinter B. (Slovenia)

7TH CONGRESS OF THE EUROPEAN SOCIETY OF CONTRACEPTION 11 WEDNESDAY, APRIL 10, 2002 18:00 - 19:30 Opening Session and Ceremony (English-Italian) PALAZZO DUCALE SALA MAGGIOR CONSIGLIO

18:00 - 18:25 • Opening spectacle 18:25 - 18:35 • President of the Organising Committee P. Crosignani (Italy) 18:35 - 18:45 • President of the ESC and of the Scientific Committee S. Skouby (Denmark) 18:45 - 19:30 • Opening Lecture 'Contraception and Society' E. Diczfalusy (Sweden)

THURSDAY, APRIL 11, 2002 08:30 - 10:00 Main Session I From Biology to Contraception (English-Italian) AUDITORIUM Chairman: S. Skouby (Denmark) Co-chairman: P. Crosignani (Italy) 08:30 - 09:00 • Steroid receptors O. Gustafsson (Sweden) (IS-01) 09:00 - 09:30 • New progestins R. Sitruk-Ware (USA) (IS-02) 09:30 - 10:00 • Implantation U. Bentin Ley (Denmark) (IS-03)

10:00 - 10:30 Coffee break

10:30 - 12:00 Parallel Sessions

GHIBLI Session 1: Abortion situation in Europe (English only) Chairman: E. Aubény (France) Co-chairman: J. Rademakers (The Netherlands)

Key-note lectures: 10:30 - 10:45 • Legislation V. Claeys (Belgium) (IS-04) 10:45 - 11:00 • Statistical information C. Blayo (France) (IS-05) 11:00 - 11:20 • Changing attitudes towards abortion E. Arisi (Italy) (IS-06)

12 7TH CONGRESS OF THE EUROPEAN SOCIETY OF CONTRACEPTION Selected free communications: 11:20 - 11:30 • First pregnancy: reproductive choice in youth Z.A. Gorodnicheva (Russia) (FC1-1) 11:30 - 11:40 • Assistance of International Agencies in the Field of SRH for the Countries of Central and Eastern Europe G. Lazdane (Latvia) (FC1-2) 11:40 -11:50 • Enduring Barries to Quality Termination Care in the UK R. Campbell (United Kingdom) (FC1-3) 11:50 - 12:00 • Developing a strategy to improve key aspects of induced abortion care in Turkey: learning lessons from Scotland L. Say (Turkey) (FC1-4)

10:30 - 12:00 Symposium Organon (English only) AUDITORIUM NuvaRing. Not your everyday contraceptive Chairman: I. Milsom (Sweden) Co-chairman: M Vree (The Netherlands) • Complete and robust ovulation inhibition with NuvaRing S. Killick United Kingdom) • High contraceptive efficacy and tolerability with NuvaRing F. Roumen (The Netherlands) • Lower hormone dosage with improved cycle control M. Vree (The Netherlands) • High acceptability and satisfaction with NuvaRing use A. Szarewski (United Kingdom)

12:00 - 13:30 Lunch

12:15 - 13:15 Meet the Experts (English only) SCIROCCO • Long acting methods Experts: A. Webb (United Kingdom), G. Bartfai (Hungary) LIBECCIO • Psychological aspects Experts: O. Loeber (The Netherlands), M. Short (Ireland) LIBECCIO • The role of the non medical professionals in contraception Experts: S. Jones (Ireland), T. Farley (WHO) LEVANTE • OC use and endometriosis Experts: P.L. Venturini (Italy), S. Ozalp (Turkey) TRAMONTANA • Contraception in PCO patients Experts: D. Cibula (Czech Republic), P.G. Crosignani (Italy) ZEFIRO • Spermicides P.F.A. Van Look (Switzerland), M. Lech (Poland)

7TH CONGRESS OF THE EUROPEAN SOCIETY OF CONTRACEPTION 13 13:30 - 15:00 Poster Session FOYER Posters manned by authors

15:00 - 16:30 Parallel Sessions

GHIBLI Session 4: Cancer and contraception (English only) Chairman: G. Benagiano (Italy) Co-chairman: N. Ragni (Italy)

Key-note lectures: 15:00 - 15:50 • Breast, ovary, endometrium and cervix C. La Vecchia (Italy) (IS-07)

Selected free communications: 15:50 - 16:00 • Contraception with amenorrhoea - an international study on acceptability A. Glasier (United Kingdom) (FC4-1) 16:00 - 16:10 • Levonorgestrel-Releasing Intrauterine System as a Contraceptive and Treatment in Women with Uterine Leiomyoma V.A. Grigorieva (USA - Russia) (FC4-2) 16:10 - 16:20 • The choice of drugs for hormone contraception in women with the history of disturbed menstrual cycle V.I. Grischenko (Ukraine) (FC4-3) 16:20 - 16:30 • Should endometrial hyperplasia be regarded as a reason for Abnormal Uterine Bleeding (AUB) in users of The Intrauterine Contraceptive Device (IUD) S. Ozalp (Turkey) (FC4-2)

Workshops (English only)

15:00 - 16:30 • IUD SCIROCCO D. Serfaty (France), G. Bartfai (Hungary) 15:00 - 16:30 • Adolescent forum LEVANTE O. Loeber (The Netherlands), V. Bruni (Italy) 15:00 - 16:30 • The Web as a teacher in the contraceptive field PONENTE R.J.C.M Beerthuizen (The Netherlands), M. Lech (Poland)

14 7TH CONGRESS OF THE EUROPEAN SOCIETY OF CONTRACEPTION 15:00 - 16:30 Symposium Leiras (English only) AUDITORIUM The Mirena levonorgestrel system: freedom of choice in long-acting contraception Chairman: A. Glasier (United Kingdom)

• Introduction to long-acting contraceptive methods A. Glasier (United Kingdom) • The Mirena levonorgestrel system: the German experience H.A. von Waldenfels (Germany) • The Mirena levonorgestrel system: effective contraception with health benefits A. Evans (United Kingdom) • Advance information has impact on user satisfaction with the Mirenalevonorgestrel intrauterine system T. Backmann (Finland) • Discussion

16:30 - 17:00 Coffee break

17:00 - 18:30 Parallel Sessions

GHIBLI Session 6: What do women want? Chairman: A. Verougstrate (Belgium) Co-chairman: E. Arisi (Italy)

Key-note lectures: 17:00 - 17:15 • Continuation and compliance of contraceptive use B. Pinter (Slovenia) (IS-08) 17:15 - 17:30 • Counselling in contraception A. Webb (United Kingdom) (IS-09)

Selected free communications: 17:30 - 17:40 • Knowledge of oral contraceptives among Norwegian adolescents by provider T. Hansen (Norway) (FC6-1) 17:40 - 17:50 • Choosing a preventive method: using health behaviour modification models to predict efficacy of contraceptive choices and contraceptive behaviour L.P. van Dalen (The Netherlands) (FC6-2)

7TH CONGRESS OF THE EUROPEAN SOCIETY OF CONTRACEPTION 15 17:50 - 18:00 • Creating a healthy respect D. Milne (United Kingdom) (FC6-3) 18:00 - 18:10 • What do women want? Offering the Standard Days Method to women in Istanbul, Turkey D. Cebeci (Turkey) (FC6-4) 18:10 - 18:20 • Do adolescentes really want what we offer them? A needs assessment in a developing country P.S. Steyn (South Africa) (FC6-5) 18:20 - 18:30 • Improving acces to contraceptive care through nurse prescribing M. Jones (United Kingdom) (FC6-6)

Workshops (English only)

17:00 - 18:30 • IUD SCIROCCO D. Serfaty (France), G. Bartfai (Hungary) 17:00 - 18:30 • Adolescent forum LEVANTE O. Loeber (The Netherlands), V. Bruni (Italy) 17:00 - 18:30 • The Web as a teacher in the contraceptive field PONENTE R.J.C.M Beerthuizen (The Netherlands), M. Lech (Poland)

FRIDAY, APRIL 12, 2002 08:30 - 10:00 Main Session II: Progestin-only contraception (English/Italian) AUDITORIUM Chairman: V. Bruni (Italy) Co-chairman: G. Creatsas (Greece)

08:30 - 09:00 • Anti-ovulatory effects of progestin preparations U. Gaspard (Belgium) (IS-10) 09:00 - 09:30 • Clinical profile of progestin contraception P. Benagiano (Itay) (IS-11) 09:30 - 10:00 • Mode of delivery systems (impact on acceptability) A. Verougstraete (Belgium) (IS-12)

10:00 - 10:30 Coffee break

10:30 - 12:00 Parallel Sessions

16 7TH CONGRESS OF THE EUROPEAN SOCIETY OF CONTRACEPTION GHIBLI Session 2: Male contraception (English only) Chairman: B. Pinter (Slovenia) Co-chairman: A. Volpe (Italy) Key-note lectures: 10:30 - 10:50 • Male contraception with androgen plus progestin F. Wu (United Kingdom) (IS-13) 10:50 - 11:10 • Other possibilities E. Nieschlag (Germany) (IS-14) 11:10 - 11:30 • Psychological aspects R.H.W. van Lunsen (The Netherlands) (IS-15)

Selected free communications: 11:30 - 11:40 • Etonogestrel implants with depot testosterone: dose-dependent suppression of spermatogenesis for longachting male contraception R.A. Anderson (United Kingdom) (FC2-1) 11:40 - 11:50 • Female contraception on male contraception O. Casian-Botez (Romania) (FC2-2) 11:50 - 12:00 • The demographic characteristics of 911 no scalpel vasectomy patients B. Dilbaz (Turkey) (FC2-3)

AUDITORIUM Symposium Schering (Yasmin) (English only) 10:30 - 12:00 Added value in oral contraception:the unique properties of Yasmin

• Welcome and Introduction J.-M. Foidart (Belgium) • Yasmin: the reason why I.H. Thorneycroft (USA) • Drospirenone – a new progestogen with antimineralocorticoid activity, resembling natural progesterone W. Oelkers (Germany) • The evaluation of a unique oral contraceptive called Yasmin in the management of premenstrual complaints E.W. Freeman (USA) • Experiences with Yasmin: the acceptability of a novel oral contraceptive and its effects on well-being D. Mansour (United Kingdom) • Conclusion J.-M. Foidart (Belgium)

7TH CONGRESS OF THE EUROPEAN SOCIETY OF CONTRACEPTION 17 12:00 - 13:30 Lunch

12:15 - 13:15 Meet the Experts (English only) SCIROCCO • Adolescent contraception Experts: G. Creatsas (Greece), V. Bruni (Italy) LIBECCIO • Non-bleeding OC regimens Experts: A. A. Glasier (Unted Kingdom), A. Yeshaya (Israel) PONENTE • Early medical abortions Experts: E. Aubény (France), A. Pretnar-Darovec (Slovenia) LEVANTE • Non-viral STD Experts: J. Orfila (France), C. LaVecchia (Italy) TRAMONTANA • Fertility regulation in the perimenopause Experts: S.O. Skouby (Denmark), P.G. Crosignani (Italy) ZEFIRO • Sexual dysfunction and contraception Experts: R.H.W. van Lunsen (The Netherlands), A. Verougstraete (Belgium)

13:30 - 15:00 Post Poster Discussion (English only) GHIBLI (selection of posters to be presented) Chairman: N.O Sjöeberg (Sweden) Co-chairman: E. Arisi (Italy), E. Aubény (France)

15:00 - 16:30 Parallel Sessions

GHIBLI Session 5: Emergency contraception (English only) Chairman: C. Coll (Spain) Co-chairman: P.L Venturini (Italy)

Key-note lectures: 15:00 - 15:15 • Clinical aspects A. Glasier (United Kingdom) (IS-16) 15:15 - 15:30 • Over the counter E. Aubény (France) (IS-17)

15:30 - 15:40 Selected free communications • To improve teenagers’ knowledge of emergency contraception (EC) A. Graham (United Kingdom) (FC5-1)

18 7TH CONGRESS OF THE EUROPEAN SOCIETY OF CONTRACEPTION 15:40 - 15:50 • Emergency contraceptive pills in Sweden; a summary of four studies T.T. Tydén (Sweden) (FC5-2) 15:50 - 16:00 • What happens when women have emergency contraception (EC) to keep at home F. Lakha (United Kingdom) (FC5-3) 16:00 - 16:10 • Surfing in an emergency: Medical queries posed by visitors to the Norlevo emergency contraception website A. Ulmann (France) (FC5-4) 16:10 - 16:20 • The pharmacist’s position in providing emergency contraception services O. Casian-Botez (Romania) (FC5-5) 16:20 - 16:30 • Non-prescription delivery of emergency contraception: perspectives from both sides of the counter E. Gainer (France) (FC5-6)

15:00 - 16:30 Workshops (English only) PONENTE Evidence based contraceptive practice J. Drife (United Kingdom), A. Webb (United Kingdom)

15:00 - 16:30 Symposium Wyeth (English only) AUDITORIUM • Loette use and the treatment of acne K. Washenik (USA) • Benefits of OC use in the perimenopausal woman J. Sanfilippo (USA) • Post Partum Depression D. Murphy (United Kingdom) • A 24-Day Regimen of Gestodene 60 mcg/Ethinyl Estradiol 15 mcg New Data F. Fruzzetti (Italy)

16:30 - 17:00 Coffee break

17:00 - 18:30 General Assembly of the European Society of Contraception AUDITORIUM (English only) (members only)

7TH CONGRESS OF THE EUROPEAN SOCIETY OF CONTRACEPTION 19 SATURDAY, APRIL 13, 2002 08:30 - 10:00 Main Session III: Sexual transmitted viral infections (English/Italian) AUDITORIUM Chairman: S. Özalp (Turkey) Co-chairman: C. LaVecchia (Italy)

08:30 - 09:00 • Hepatitis A.R. Zanetti (Italy) (IS-18) 09:00 - 09:30 • HIV A. Semprini (Italy) (IS-19) 09:30 - 10:00 • HPV J. Paavonen (Finland) (IS-20)

10:00 - 10:30 Coffee break

10:30 - 12:00 Parallel Sessions

AUDITORIUM Session 3: Oral contraception and CVD (English only) Chairman: M. Short (Ireland) Co-chairman: D. Cibula (Czech Republic)

Key-note lectures: 10:30 - 11:00 • Biologic effects J. Jespersen (Denmark) (IS-21) 11:00-11:30 • Epidemiologic effects T. Farley (WHO) (IS-22)

Selected free communications: 11:30 - 11:40 • Effect of a biphasic oral contraceptive containing desogestrel on glucose metabolism of women with polycystic ovary syndrome A. Cagnacci (Italy) (FC3-1) 11:40 - 11:50 • Oral contraception in late reproductive age and in perimenopausal period N.M.Pasman (Russia) (FC3-2) 11:50 - 12:00 • Effect of oral contraceptives on the CVD risk marker hsCRP M. van Rooijen (Sweden) (FC3-3)

20 7TH CONGRESS OF THE EUROPEAN SOCIETY OF CONTRACEPTION 12:00 - 13:30 Lunch

13:30 - 15:00 Main Session IV (English/Italian) AUDITORIUM Chairman: D. Serfaty (France) Co-chairman: P. Crosignagni (Italy)

13:30 - 14:00 • Future contraception, from research to practice D. Baird (United Kingdom)

14:00 - 14:15 Best Poster Price

14:15 - 15:00 Closing Remarks

7TH CONGRESS OF THE EUROPEAN SOCIETY OF CONTRACEPTION 21 POSTERS

Poster area: level 0 (Foyer ‘Grecale’) Poster presentations will carry equivalent scientific status to oral communications in the programme Posters will be on display for the full time of the Congress and will be mounted on Wednesday April 10. On Thursday April 11 (13:30 - 15:00), a 'Posters manned by authors' session will be organised. On Friday April 12, a plenary poster session (13:30 - 15:00) of selected posters will be scheduled (the selected posters will be clearly marked on beforehand). Authors of the selected posters should present themselves at the registration desk on Friday for further instructions. The best poster prize will be awarded during the Closing Ceremony on Saturday.

Posters will be grouped in the poster area by topic: • Abortion situation in Europe • Male contraception • Oral contraception and CVD • Cancer and contraception • Emergency contraception • What do women want?

TOPIC 1: ABORTION SITUATION IN EUROPE P1-01 Evaluation of postabortion IUD insertion in Egyptian women A. Moussa (Egypt)

P1-02 The problems of demographic situation in Latvia M. Orleana and D. Baumane (Latvia)

P1-03 The decision to voluntary abort shows a seasonal frequency resembling that of suicides A. Cagnacci, A. Volpe (Italy

P1-04 Changes in abortion and contraception situation in Czech Republic T. Fait, J. Kocourková , R. Uzel, J. Sracek (Czech Republic)

22 7TH CONGRESS OF THE EUROPEAN SOCIETY OF CONTRACEPTION P1-05 First experiences with the abortion pill in The Netherlands J. Rademakers (The Netherlands)

P1-06 A teenage pregnancies audit in a small North London district P. Blencowe, A. Deacon, C. Frances (United Kingdom)

P1-07 Vaginal misoprostol for preoperative cervical priming in first trimestr mulliaparae L. Camli, L. Erkan, L. Hiçyilmaz, L. Çimen, F. Soylu (Turkey)

P1-08 Repeat Abortion I.S. Savelieva, Z.A. Gorodnicheva (Russia)

P1-09 Abortion: how do men react to it? M. Maragno, P. Battaglia, C. Rossi, S. Chiodi, G.B. Ravera (Italy)

P1-10 Demographic and contraceptive usage profile under 16s requesting termination of pregnancy in Leeds S.S.M. Wong and B.A. Gbolade (United Kingdom

P1-11 Assessing the quality of patient information leaflets about abortion methods in England and Wales S.S.M. Wong, H.L. Bekker, J.G. Thornton, B.A.Gbolade (United Kingdom)

P1-12 The decline in induced abortion in Italy A. Spinelli, M.E. Grandolfo, M. Pediconi, F. Timperi, S. Andreozzi, M. Bucciarelli (Italy)

P1-13 Overview of abortion complications, their clinical treatment and outcome P. Mitrovic, A. Mladenovic-Mihailovic, B. Lazovic (Yugoslavia)

P1-14 Overview of the rate of abortion in females 18 years old and younger B. Lazovic, P. Mitrovic, S. Mavric (Yugoslavia)

P1-15 New contraceptive technologies for women of high pregnancy risk N.A. Kayupova (Kazakhstan)

P1-16 Abortion at extreme ages O. Casian-Botez, D.S. Tomosoiu, L. Coca, M. Flondor, S. Ursu, L. Nechita (Romania)

7TH CONGRESS OF THE EUROPEAN SOCIETY OF CONTRACEPTION 23 P1-17 Changing Abortion Trends in Estonia in 1992-2000 K. Haldre, H. Karro, A. Tellmann (Estonia)

P1-18 Abortion of Teenagers G. Gyorfi (Hungary)

P1-19 Abortion as a leading way of family planning G. Gregoric (Yugoslavia)

P1-20 Abortions and maternal mortality in Russia A.N. Yusupova, O.S. Alyautdina and A.D. Makatsaria (Russia)

TOPIC 2: MALE CONTRACEPTION

P2-01 The project on health education of men on family planning and sexually transmitted diseases in the province of Balikesir, Turkey S. Ozalp, H. Hassa, S. Koral, T. Cevikbilen, H. Satiroglu (Turkey)

TOPIC 3: ORAL CONTRACEPTION AND CVD P3-01 Estimation of efficiency of using combined oral contraceptive in girls K.G. Serebrennikova, E.A. Pashukova, E.P. Kuznecova and V.F. Menyasheva (Russia)

P3-02 Frequency of Factor V Leiden mutation in women using oral contraceptives E.K. Ailamazian and M.A. Tarassova (Russia)

P3-03 Experience of use of monophase hormone contaceptives by the girls of nursing school G.A. Ushakova, M.P. Gvozdetskaya, S.I. Elguina (Russia)

P3-04 The influence of emergency contraception pills in our practice A. Weidner, F. Tamási, S. Bagdány (Hungary)

P3-05 The changes of subjective symptoms afther 6 months treatment with four diffrent pills F. Tamási, A. Weidner, S. Bagdány (Hungary)

24 7TH CONGRESS OF THE EUROPEAN SOCIETY OF CONTRACEPTION P3-06 Hyperandrogenation and ways of its correction at women with a set of symptoms of polycystic ovaries V.V. Podolsky (Ukraine)

P3-07 Our experience with Logest-low dosage oral contraceptive from Schering J. Georgievska, S. Georgieva, J. Tofoski, S. Popovska, G. Georgievski (Macedonia)

P3-08 Low dose oral contraception and its effect on bleeding pattern in adolescent period M. Pavlov-Mirkovic, M.Bogavac (Yugoslaviav)

P3-09 Inherited thrombophilia and hormonal contraception A.D. Makatsaria, N.V. Dolgushina, V.O. Bitsadze and M.A. Djangidze (Russia)

TOPIC 4: CANCER AND CONTRACEPTION

P4-01 Using of combined oral contraceptives by old reproductive women for medical purpose K.G. Serebrennikova, E.A. Pashukova and E.E. Gorbunova (Russia)

P4-02 The clinical appearance of PID with or without IUD use in Lativa I. Viberga, G. Lazdane, V. Odlind, J. Kroica (Latvia)

P4-03 Intrauterine devices and risk for inflammatory tumours S. Milosevic, M. Bogavac (Yugoslaviav)

P4-04 Pathogenic treatment of uterine leiomyoma and adenomyosis by low-dose oral contraceptive Novynette A.L. Tikhomirov and D.M. Lubnin (Russia)

7TH CONGRESS OF THE EUROPEAN SOCIETY OF CONTRACEPTION 25 TOPIC 5: EMERGENCY CONTRACEPTION P5-01 (No title) H. Kettle (United Kingdom)

P5-02 Reproductive health disturbances in women, living on polluted areas L.J. Davidov, O.Z. Hnateyko, S.O. Pechenyk, Z.M. Fedorishin, N.I. Kytsera (Ukraine)

P5-03 IntraUterine Device Insertions: Setting our standards A.P. Kasliwal, A. Webb (United Kingdom)

P5-04 ostinor® - A choice for emergency contraception in adolescents S. Tanchev, B. Shetov (Bulgaria)

P5-05 Expression of plasminogen activators in human endometrial stromal cells during implantation C. Papp, Z. Ban (Hungary)

P5-06 Primary Care Professionals’ Views on Increasing Acces to Emergency Contraception P. Seaman, K. Fairhurst, S. Wyke, S. Ziebland, A. Glasier (United Kingdom)

P5-07 Emergency contraception among adolescent girls V. Hirsl-Hecej, N. Sikanic-Dugic, T. Turudic-Pavelic (Croatia)

P5-08 Emergency contraception with levonorgestrel only pills, the Hungarian experience L. Kamár, L. Kovács, A. Pál (Hungary)

P5-09 Emergency contraception in women sufferred from sexual abuse V.N. Prilepskaya, T.N. Bebneva (Russia)

P5-10 Four-year clinical experiences with two new copper/silver and copper/gold alloy intrauterine contraceptive devices I. Batar (Hungary)

26 7TH CONGRESS OF THE EUROPEAN SOCIETY OF CONTRACEPTION TOPIC 6: WHAT DO WOMEN WANT

P6-01 The comparative analysis of contraceptive behaviour and requirements of the women of various ages M.B. Khamoshina, L.A. Kaygorodova, L.V. Sedaya (Russia)

P6-02 Affect of antepartum and early postpartum family planning counselling on contraceptive choices with regard to fertility goal B. Dilbaz, E. Caliskan, B. Aykan, O. Akyuz, E. Giray, S. Gungor and A. Haberal (Turkey)

P6-03 Development of a novel intrauterine levonorgestrel-releasing system for treatment and contraception: initial clinical experience D. Janssens , D. Wildemeersch and M. Thiery (Belgium)

P6-04 Emergency contraception for teenagers with Levonorgestrel - Efficacy, tolerability and level of informedness G. Kolarov, A. Dimitrov, M. Sirakov, A. Nikolov (Bulgaria)

P6-05 Cycle control, side effects and satisfaction from the use of two low and lower-dose oral contraceptives in a multicenter study G. Kolarov, A. Dimitrov, A. Nikolov (Bulgaria)

P6-06 A comparison of the cycle control, lipid metabolism and side effects of two monophasic oral conrtceptives containing 30 an 20 micrograms ethinylestra diol and 150 micrograms desogestrel G. Kolarov, A. Dimitrov, A. Nikolov (Bulgaria)

P6-07 Contraeception and treatment in the perimenopause with a novel "frameless" intrautrine levonorgestrel-releasing drug delivery system: an extended pilot study D. Wildemeersch , E. Schacht , P. Wildemeersch (Belgium)

P6-08 Interest of systematic screening for Chlamydia Trachomatis in young women consulting for contraception J. Orfila , J. Mention , J.M. Sueur (France)

P6-09 Weight change during the use of low-dose oral contraceptives, containing 20 mcg ethinyloestradiol and 75 mcg of gestodene M.M. Lech , L. Ostrowska (Poland)

7TH CONGRESS OF THE EUROPEAN SOCIETY OF CONTRACEPTION 27 P6-10 Rhogam in First Trimester Abortions: Necessity or Convention? S. Kim, C. Westhoff, S. Brown (USA)

P6-11 The reliability and efficacy of a hormone monitoring device for fertility control M. Guida, S. Bramante, G. Acunzo, G. Lavitola, M. Pellicano, D. Cirillo, C. Nappi (Italy)

P6-12 Family Planning Services: Yorkshire Region Pill Audit J. Murty (United Kingdom)

P6-13 A new birth control method: the FemCap A. Shihata (USA)

P6-14 A new birth control method with dual action: the FemCap A. Shihata (USA)

P6-15 Reproductive potential of girls - teenagers of now adays in Kemerovo S.I. Elguina, G.A. Ouchakova (Russia)

P6-16 Rights, Respects, Responsibility® - Plenary or Keynote B.K. Huberman (United Kingdom)

P6-17 Diyarbakir Family Health Education, Counselling and Service Provision Project S. Koral , H. Satiroglu , S. Gösterici , H. Hassa , S. Ozalp (Turkey)

P6-18 The characteristics of the patients to whom IUD was applied in the family planning division of a university clinic in Turkey: a review of ten years’ experience D. Öztürk, N. Erkan, A. Gezer; E. Karamanoglu, H. Seyisoglu, F. Aksu (Turkey)

P6-19 The evaluation of 1 year follow-up of post-abortive and interval intrauterine device applications (totally 1685 cases) K. Ertopcu, Z. Benli, S. Yagceken, Z. Ozenc, N. Piskin, I. Ozelmas (Turkey)

P6-20 Evaluation of 100 cases who have pregnancies with intrauterine devices and want their pregnancies to continue K. Ertopcu, E. Undar, M. Inal, S. Tinar, I. Ozelmas (Turkey)

28 7TH CONGRESS OF THE EUROPEAN SOCIETY OF CONTRACEPTION P6-21 Demographic analysis postabortive and interval hormonal contraceptive method applicated cases K. Ertopcu, G. Undar, Z. Benli, H. Unluoglu, S. Coskun, M. Inal, I. Ozelmas (Turkey)

P6-22 5 years follow-up of intrauterine devices applicated during cesarian sections K. Ertopcu, H. Unluoglu, A. Donmez, O. Bicer, I. Ergin, I. Ozelmas (Turkey)

P6-23 Oral contraception in 16-25 years old women (students) - adressability, accessibiltity and choice at the National Center of Family Planning and Contraception Bucharest Romania C.E. Neagu, A. Constantin, V.E. Popescu, M.S. Neagu (Romania)

P6-24 Male involvement in family planning and reproductive health Z.A. Gorodnicheva, I.S. Savelieva (Russia)

P6-25 Emotional Response to First Intercourse and Contraception Use among Adolescents G.C. Hess, M.A. Chan, and H. Denkhaus (Canada)

P6-26 The incidence of sterilisation and its reversal in the United Kingdom S. Rowlands , P. Hannaford (United Kingdom)

P6-27 Effect of extra low dose OC on cycle control in adolescents A. Korenek, M.Vyslouzil, I. Sabo, S. Liptay (Czech Republic)

P6-28 Can oral contraceptives affect the olfactory sensitivity? A prospective study on pill users S. Caruso , C. Grillo , C. Agnello , L. Maiolino , G. Intelisano , M. Farina , L. Di Mari , A. Serra (Italy)

P6-29 A two years personal survey of implanon activity in UK S. Gupta (United Kingdom)

P6-30 Family building status, quality of care and 18 year continuation with a Copper T380 I. Sivin , M. Pavez , A. Biswas , S. Diaz , K.J. Beebi , T. McCarthy (USA)

P6-31 AIDS: Top Level Policy and Decision Makers’ Initiative in Turkey Project H. Hassa , H. Satiroglu , S. Koral , T.Z. Bazer , S. Ozalp (Turkey)

7TH CONGRESS OF THE EUROPEAN SOCIETY OF CONTRACEPTION 29 P6-32 Reproductive health among Italian adolescents: knowledge, attitude practice and behaviour S. Donati, S. Andreozzi, E. Medda, M.E. Grandolfo (Italy)

P6-33 Sexual and reproductive behaviour of universities’ students: their needs I.S. Savelieva, Z.A. Gorodnicheva (Russia)

P6-34 A contraceptive service at an African Well Women clinic H. Gordon, N. Morris, B. Reed, C. Francis (United Kingdom)

P6-35 Patients satisfaction, side-effects and removal-rate with Implanon® in Switzerland S. Tschudin, A. Kang, W. Holzgreve, J. Bitzer (Switzerland)

P6-36 Partner acceptability to the new contraceptive vaginal ring, NuvaRing F.J.M.E. Roumen , M.L. Vree (The Netherlands)

P6-37 Onset and prevalence of common adverse events with NuvaRing F.J.M.E. Roumen , M.L. Vree (The Netherlands)

P6-38 Influence of user age and contraceptive history on satisfaction with NuvaRing M.L. Vree, G.R. Lounsbach (The Netherlands)

P6-39 User acceptability with a new method of combined contraception, NuvaRing M.L. Vree, G.R. Lounsbach (The Netherlands)

P6-40 Feeling NuvaRing during intercourse - a detailed analysis M.L. Vree, G.R. Lounsbach (The Netherlands)

P6-41 Is user satisfaction with NuvaRing affected by feeling the ring during intercourse? G.R. Lounsbach, M.L. Vree (The Netherlands)

P6-42 The effect of NuvaRing on lipid metabolism and hemostasis; two comparative studies M. Tuppurainen , S.D. Magnùsdóttir (Iceland)

30 7TH CONGRESS OF THE EUROPEAN SOCIETY OF CONTRACEPTION P6-43 The effect of a triphasic oral contraceptive containing desogestrel on seborrhea and acne V.N. Prilepskaya, E.A. Mejevitinova, E.V. Gogaeva, V.V. Yaglov (Russia)

P6-44 Observational evaluation of the effect of a combiphasic oral contraceptive on cycle control and acne L.Z. Horvath , F.C.H.M. Rutten (Hungary)

P6-45 Effects of a low dose oral contraceptive on body weight in young women P.N. Krotin, L.V. Merculova, T.U. Kozhuhovskaya, N.B. Beridze, L.L. Shakatova (Russia)

P6-46 Bleeding pattern with Cerazette®: trends over time O.J.B. de Smit (The Netherlands)

P6-47 Body weight and fat distribution in women using a low-dose oral contraceptive A. Evseev (Russia)

P6-48 Spanish survey on the importance of skin: perspective of physician and woman F.C.H.M. Rutten , A.J.G.J. Koeklink , R.H. Blades , D. Wellings (The Netherlands)

P6-49 Effect on bleeding patterns following the use of a low dose desogestrel-containing oral contraceptive P. Lavin, C. Bravo (Chili)

P6-50 Localization of non-palpable single-rod contraceptive implants using ultrasound sonography M.C.J. Kaptein , R. Ganpat (The Netherlands)

P6-51 Implanon and women with high body weight M.C.J. Kaptein, H.J. Out (The Netherlands)

P6-52 Th estrogen dose in the pill: how low should we go? M.L. Vree (The Netherlands)

P6-53 Contraception with etonogestrel implant: an Portuguese experience T. Bombas, M. Tavares, G. Carvalho, T. Sousa Fernandes (Portugal)

P6-54 What girls don’t want, what girls desire: a systematic approach of sexuality education J. Reinders (The Netherlands)

7TH CONGRESS OF THE EUROPEAN SOCIETY OF CONTRACEPTION 31 P6-55 Need for Family Planning Education among high-school girls in Novi Sad, Yugoslavia A. Kapamadzija, J. Vulkelic, M. Pavlov-Mirkovic, Lj, Milasinovic, A. Bjelica (Yugoslaviav)

P6-56 Multimodal contraception in family planning and in health protection of women M. Pavlov-Mirkovic, M. Bogavac (Yugoslaviav)

P6-57 Intrauterine device and chlamydia trachomatis infection M. Bogavac, S. Milosevic, M. Pavlov-Mirkovic (Yugoslaviav)

P6-58 Contraception and the risk of chlamydia trachomatis infection M. Bogavac M, M. Pavlov-Mirkovic, S.Milosevic (Yugoslaviav)

P6-59 Contraceptive expectations and attitudes among Bulgarian teenagers T. Chernev (Bulgaria)

TOPIC 7: OTHER TOPICS P7-01 Long term tolerability of very low-dosed combined oral contraception containing 20 µg of Ethinylestradiol and 75 µg of Gestodene D. Driák, J. Zmrhal (Czech Republic)

P7-02 Endometrial spiral and chronic diseases of female sexual organs V.V. Podolsky, V.A. Dronova (Ukraine)

P7-03 Are postcoital IUD insertions at increased risk of insertion-related complications M.A. Farmer (United Kingdom)

P7-04 Setting up an education unit within an family planning service - Pros and Cons P. Blencowe (United Kingdom)

P7-05 The gynefix intrauterine contraveptive implant in nulliparous women A.D. Forti, M. Payne , B. McDonald (United Kingdom)

P7-06 Audit of outcome following positive Chlamydia result in Community Family Planning Clinic R. Tolcher (United Kingdom)

32 7TH CONGRESS OF THE EUROPEAN SOCIETY OF CONTRACEPTION P7-07 Characteristics of adolescent pregnancies in two different hospitals in the same city S. Ozalp , M. Tanir , A. Kabukçuoglu , S. Yazan , A.E. Keskin (Turkey)

P7-08 Health risks of Early (≤19) and late ( ≥35) childbearing S. Ozalp , T. Sener , M. Tanir , S. Yazan , A.E. Keskin (Turkey)

P7-09 Tuboovarian Abscess (TOA In Intrauterine Device (IUD) Users M. Tanir, H. Hassa, S. Ozalp, M. Kaya, T. Oge (Turkey)

P7-10 Our experiences with Mycosyst-Gyno capsule M. Palczert, J. Kerényi, F. Tamási, A. Weidner, S. Bagdány (Hungary)

P7-11 Result of het histopathologic evaluation of tubal ligation materials S. Ozalp, O.T. Yalçin, A. Yildirim, M. Uray (Turkey)

P7-12 The evaluation of adolescent pregnancy in Izmir obstetrics and gynecology hospital D. Askit Unver, G. Yukselen, M. Gunay, U. Kirca (Turkey)

P7-13 Communication on contraception and knowledge about oral contraception amongst Norwegian high school students T. Hansen and F.E. Skjeldestad (Norway)

P7-14 Feritility after non-complicated and complicated IUD use G. Garmo and F.E. Skjeldestad (Norway)

P7-15 Oral contraceptives and compliance among Norwegian adolescents G. Garmo, T. Øvreness and F.E. Skjeldestad (Norway)

P7-16 An open randomized trial of two copper-IUDS, NOVA T®380 versus Gyne T®380 Slimline: three-year results F.E. Skjeldestad and K. Elomaa (Norway)

P7-17 Availability of oral contraceptives free of charge and induced pregnancy rates among teenagers - results from a municipality based intervention study in Norway F.E. Skjeldestad (Norway)

7TH CONGRESS OF THE EUROPEAN SOCIETY OF CONTRACEPTION 33 P7-18 Attitudes towards contraceptive pill use in two different populations in Thrace-Greece G. Galazios, K. Dafopoulos, V. Liberis, N. Koutlaki, P. Tsikouras, P. Anastasiadis (Greece)

P7-19 Cycle Control with Combiphasic Hormonal Contraception M. Havlin, (Czech Republic

P7-20 Developing a rabbit model for progestagen only related breakthrough bleedings R. Ubink, J. van Rozendaal, H. van Diepen, P. Verbost (The Netherlands)

P7-21 Differential approach in treatment of patients with hyperandrogenia N.M.Pasman, T.V.Botkina, M.P.Dobrova, A.V. Dudareva (Russia)

P7-22 Experience of combined abortion and laparoscopic sterilisation with Filshie Clips B.A. Gbolade and S. Saxena (United Kingdom)

P7-23 A proposal for a European Minimum National Dataset for Termination of Pregnancy Services B.A. Gbolade (United Kingdom)

P7-24 Clinical experience with Implanon in a Fertility Control Unit B.A. Gbolade and S. Wong (United Kingdom)

P7-25 Implanon: reducing clinic follow-up attendance default rates by telephone appointments B.A. Gbolade, G. Ramsden, S. Wong and E. Hasan (United Kingdom)

P7-26 Adolescent contraception. Problems and solutions in a major industrial region of post communist Ukraine Y.S. Parashchuk and I.A. Tuchkina (Ukraine)

P7-27 Contraception: The Board game N.H. Mullin and B. Hastings-Asatourian (United Kingdom)

34 7TH CONGRESS OF THE EUROPEAN SOCIETY OF CONTRACEPTION EXHIBIT AND SPONSORS

(in alphabetic order)

Level A Organon NV Schering Aktiengesellschaft Wyeth-Ayerst Pharmaceuticals

Level B

Level C Amsa ACR Angelini Eurim-Pharm Vertriebs GmbH & Co KG Exelgyn Laboratories Farmades s.p.a. Kessel Sexual Health Care Marketing & Vertriebs GmbH Parthenon Publishing, A CRC Press Co Prosan International B.V. Rottapharm s.p.a.

Exhibit The exhibit is situated in block 7 and 8 (1st floor). Delegates are encouraged to visit the exhibition stands and to recognise the valuable financial support which the companies have provided towards the congress.

Opening hours exhibit • Wednesday, April 10, 2002 Exhibit not open yet • Thursday, April 11, 2002 09:00 – 17:00 • Friday, April 12, 2002 09:00 – 17:00 • Saturday, April 13, 2002 09:00 – 13:30

ESC desk A stand of the European Society of Contraception will be integrated in the registra- tion area. Come and visit us. We will be glad to answer your questions on your mem- bership or to inform you on the benefits of being a member. If you are not a member yet ... what are you waiting for?

7TH CONGRESS OF THE EUROPEAN SOCIETY OF CONTRACEPTION 35 For service and/or company information, please contact:

NV ORGANON ACR ANGELINI P.O. Box 20 Ple della Stazione snc 5340 BH Oss Spalomba Pomezia, Roma The Netherlands Italy Tel. +31 412 66 12 70 Tel. +39 06 9104 5263 Fax +31 412 66 25 23 Fax +39 06 9104 5308 [email protected] www.organon.com EURIM-PHARM Vertriebs GmbH & Co KG Walser Bundesstraße 273 SCHERING Aktiengesellschaft 5071 Wals Müllerstraße 178 Austria 13342 Berlin Tel. +43 662 854141-40 Germany Fax +43 662 854141-48 Tel. +49 30 4681 54 12 [email protected] Fax +49 30 4681 66 21 [email protected] FARMADES s.p.a. www.schering.de Via di Tor Cervara 282 00155 Rome WYETH-AYERST PHARMACEUTICALS Italy 500 Arcola RD Tel. +39 06 228901 Collegeville , PA 19426 Fax +39 06 2286364 USA Tel. +1 610 902 4351 KESSEL SEXUAL HEALTH CARE Fax +1 610 964 3949 MARKETING & Vertriebs GmbH [email protected] Kelsterbacher Str. 28 www.ahp.com 64546 Moerfelden-Walldorf Germany AMSA Tel. +49 6105 20 37 20 Passeggiata di Ripetta 22 Fax +49 6105 455 901 00185 Rome [email protected] Italy Tel. +39 06 3240650 Fax +39 06 3241284

36 7TH CONGRESS OF THE EUROPEAN SOCIETY OF CONTRACEPTION PARTHENON PUBLISHING, A CRC Press Co Richmond House White Cross, South Road Lancaster LA1 4 XQ United Kingdom Tel. +44 1524 585 700 Fax +44 1524 585 718

PROSAN International BV IJsselburcht 3 P.O. Box 5486 6802 EL Arnhem The Netherlands Tel. +31 26 365 33 63 Fax +31 26 365 33 69 [email protected]

ROTTAPHARM s.p.a. Via Valosa di Sopra 9 20052 Monza (RI) Italy Tel. +39 039 739 03 50 Fax +39 039 739 03 93 [email protected]

7TH CONGRESS OF THE EUROPEAN SOCIETY OF CONTRACEPTION 37 NOTES

38 7TH CONGRESS OF THE EUROPEAN SOCIETY OF CONTRACEPTION 7TH CONGRESS OF THE EUROPEAN SOCIETY OF CONTRACEPTION 39 40 7TH CONGRESS OF THE EUROPEAN SOCIETY OF CONTRACEPTION